Metraipolis › archive › dc_a8d920aef34c
Atorvastatin as a pleiotropic anticancer agent: mechanisms, evidence, and therapeutic repurposing potential — Europe PMC PMID:42112329
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42112329
- DOI
- 10.3389/fimmu.2026.1808729
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T07:35:34.452Z
- SHA-256 of the archived text
cdba58c5f3e050db8e261f26cf41a032419c28dc9ff2fde0f28fe1b127a85c16- Stable URL of this page
https://metraipolis.com/documento/dc_a8d920aef34c
How to cite
Atorvastatin as a pleiotropic anticancer agent: mechanisms, evidence, and therapeutic repurposing potential — Europe PMC PMID:42112329 — Europe PMC (en), https://europepmc.org/article/MED/42112329 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a8d920aef34c (Metraipolis archive dc_a8d920aef34c, sha256 cdba58c5f3e050db8e261f26cf41a032419c28dc9ff2fde0f28fe1b127a85c16)
BibTeX
@misc{dca8d920aef34c,
title = {Atorvastatin as a pleiotropic anticancer agent: mechanisms, evidence, and therapeutic repurposing potential — Europe PMC PMID:42112329},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42112329},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a8d920aef34c; sha256 cdba58c5f3e050db8e261f26cf41a032419c28dc9ff2fde0f28fe1b127a85c16},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42112329. Agents can read the archived copy with the MCP tool read_document.